THE National Biosafety Authority (NBA) says it has approved a clinical trial of an HIV vaccine to be undertaken by the Centre for Health Research in Zambia (CFHRZ). According to a statement issued by NBA Communications Officer Sandra Lombe, Wednesday, NBA Chief Executive Officer Lackson Tonga said the permit granted to CFHRZ was for conducting research trials in Zambia and that it was valid for three years. “THE National Biosafety Authority (NBA) has approved a clinical trial of an HIV vaccine to be undertaken by the Centre for Health Research in Zambia (CFHRZ). And the NBA last year granted 39 permits for products which may contain genetically modified organisms (GMOs). The NBA Board during its extraordinary meeting held last week,...